Company
Headquarters: Shanghai, China
CEO: Mr. Duane Lee
TW$1.82 Billion
TWD as of July 1, 2024
US$55.9 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Cowealth Medical Holding Co., Ltd. operates as a medical distribution company primarily in the diagnostic clinical laboratory field in Greater China market. It also specializes in reagent, cross-strait hospital department cooperation, and radiotherapy fields. In addition, the company undertakes the Summit project, which consolidates outside procurement of diagnostic reagents at prices as before; and provides related with related logistics management services. The company was founded in 1997 and is based in Shanghai, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Cowealth Medical Holding Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4745 wb_incandescent